Yuhan Corp. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
354,111
427,668
479,946
486,434
501,076
474,555
Total Accounts Receivable
222,095
239,569
235,384
248,623
293,560
356,384
Inventories
141,441
172,305
242,349
310,649
271,184
248,860
Other Current Assets
1,877
1,723
1,705
2,635
3,693
31,163
Total Current Assets
719,524
841,265
959,384
1,048,340
1,069,513
1,110,962
Net Property, Plant & Equipment
225,099
236,362
307,829
333,947
355,412
343,307
Total Investments and Advances
552,353
520,671
591,171
634,883
629,038
655,854
Intangible Assets
9,821
9,714
11,836
15,872
25,737
33,783
Other Assets
6,594
7,016
8,731
11,360
12,709
25,533
Total Assets
1,513,969
1,615,972
1,880,329
2,045,941
2,094,673
2,173,813
ST Debt & Current Portion LT Debt
33,600
46,100
65,600
56,350
18,486
Accounts Payable
111,069
125,679
151,445
142,133
97,842
Income Tax Payable
12,004
17,116
20,648
22,693
21,756
Other Current Liabilities
71,612
66,251
118,938
103,257
138,230
Total Current Liabilities
228,285
255,147
356,631
324,433
276,314
Long-Term Debt
18,500
24,100
86,000
140,250
115,339
Provision for Risks & Charges
6,701
33,418
43,946
47,080
62,137
Deferred Taxes
28,643
23,832
26,405
31,202
31,410
Other Liabilities
3,018
2,667
2,028
4,885
885
Total Liabilities
285,723
340,107
516,389
549,389
488,348
Common Equity (Total)
1,228,246
1,275,865
1,363,940
1,496,552
1,599,978
Total Shareholders' Equity
1,228,246
1,275,865
1,363,940
1,496,552
1,599,978
Total Equity
1,228,246
1,275,865
1,363,940
1,496,552
1,606,325
Liabilities & Shareholders' Equity
1,513,969
1,615,972
1,880,329
2,045,941
2,094,673
Accumulated Minority Interest
-
-
-
-
6,347

About Yuhan

View Profile
Address
Yuhan Building
Seoul SL 06927
Korea, Republic Of
Employees -
Website http://www.yuhan.co.kr
Updated 07/08/2019
Yuhan Corp. engages in the manufacture of pharmaceutical, health foods, cosmetics and consumer products. It operates through the following business areas: Pharmaceutical, Household products and Active Pharmaceutical Ingredient (API). Its products include APIs and intermediates and finished products such as ethical drugs, over-the-counter drugs and others.